2004N-0181 - Critical Path Initiative; Establishment of Docket
FDA Comment Number : EC26
Submitter : Ms. Susan Krivacic Date & Time: 08/02/2004 07:08:50
Organization : PBG Consulting
Private Industry
Category :
Issue Areas/Comments
Comment Issues
1. Hurdle Identification. Please describe the product development issue, the nature of the evaluation tool that is out-of-date or absent, how this problem hinders product development, and how a solution would improve the product development process.